ERBB2 and breast carcinoma: Studies using this technology have identified the most commonly mutated genes in breast cancer, which include PIK3CA, p53, and Her2 amplification mutations in 15% to 30% of breast cancers, although many other candidate genes are present in frequencies <5% [31].